Clinical Analysis of Central Serous Chorioretinopahy.
- Author:
Kyung Chul YOON
1
;
Man Seong SEO
;
Moon Ky LEE
;
Yeoung Geol PARK
Author Information
1. Department of Ophthalmology Chonnam University Medical School, Kwangju, Korea.
- Publication Type:Original Article
- Keywords:
Central serous chorioretinopathy;
Laser therapy;
Recurrence
- MeSH:
Central Serous Chorioretinopathy;
Fluorescein Angiography;
Humans;
Ink;
Laser Therapy;
Light Coagulation;
Male;
Recurrence;
Retina;
Visual Acuity
- From:Journal of the Korean Ophthalmological Society
1998;39(2):327-335
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
To evaluate the clinical aspects of central serous chorioretinopathy, the patients were analysized and divided into three groups: group I) initial visitants; group II) those who undertook fluorescein angiography; and group III) those who had been followed over 3 months. The overall frequency of this disease was 0.69%. In group I, of 262 patients, 76.5% was male, 85.5% in the forth and fifth decades and 7.7% bilateral. In group II, of 130 eyes (120 patients), only neurosensory retina was detached in 121 eyes. Of which 106 eyes (87.6%) which had ink blot leakage and 95 eyes (78.5%) had one leakage point. In 96 eyes (79.3%), leakage point located within one disc from the fovea. In group III, of 105 eyes (95 patients), initial visual acuity was better than 0.7 in 58 eyes (55.2%) and worse than 0.3 in 14 eyes (13.3%). Final visual acuity was better than 0.7 in 94 eyes (89.5%) and worse than 0.3 in 4 eyes (4.0%). In 34 eyes which were laser-treated, duration of recovery (10.8 vs 6.4 weeks; P=0.016) and frequency of recurrence (42.3 vs 17.6%; P=0.013) decreased to a statistically significantly compared with 71 conservatively treated eyes. Central serous chorioretinopathy has the high possibility of recurrence and therefore should be followed up periodically for possible need for laser photocoagulation.
